rxstat › Classes › Lipid Modifying Agents, Plain

Lipid Modifying Agents, Plain: shortage status in Canada

10 of the 16 lipid modifying agents, plain rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Atorvastatin (Lipitor) Partial shortage 7 of 64 reported products affected · est. return Jun 1, 2027 Cholestyramine Resin (Olestyr) Partial shortage 1 of 4 reported products affected · est. return Oct 3, 2027 Colestipol Partial shortage 1 of 3 reported products affected Ezetimibe (Ezetrol) Partial shortage 5 of 18 reported products affected Fluvastatin (Lescol Xl) Partial shortage 1 of 3 reported products affected · est. return Aug 31, 2026 Gemfibrozil Partial shortage 1 of 3 reported products affected Lovastatin Partial shortage 2 of 10 reported products affected Pravastatin (Pravachol) Partial shortage 12 of 49 reported products affected · est. return Sep 11, 2026 Rosuvastatin Partial shortage 9 of 65 reported products affected · est. return Aug 7, 2026 Simvastatin (Zocor) Partial shortage 15 of 65 reported products affected · est. return Dec 25, 2026 Alirocumab (Praluent) No current shortage Bezafibrate (Bezalip) No current shortage Colesevelam (Lodalis) No current shortage Evolocumab (Repatha) Discontinued 0 of 1 reported products affected Fenofibrate (Lipidil Ez) No current shortage Nicotinic Acid (Niaspan Fct) Discontinued 0 of 6 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.